Literature DB >> 18718537

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Marta G Vucković1, Ruth I Wood, Daniel P Holschneider, Avery Abernathy, Daniel M Togasaki, Alexandra Smith, Giselle M Petzinger, Michael W Jakowec.   

Abstract

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse serves as a model of basal ganglia injury and Parkinson's disease. The present study investigated the effects of MPTP-induced lesioning on associative memory, conditioned fear, and affective behavior. Male C57BL/6 mice were administered saline or MPTP and separate groups were evaluated at either 7 or 30 days post-lesioning. In the social transmission of food preference test, mice showed a significant decrease in preference for familiar food 30 days post-MPTP compared to controls. Mice at both 7 and 30 days post-MPTP lesioning had increased fear extinction compared to controls. High Performance Liquid Chromatography analysis of tissues homogenates showed dopamine and serotonin were depleted in the striatum, frontal cortex, and amygdala. No changes in anxiety or depression were detected by the tail suspension, sucrose preference, light-dark preference, or hole-board tests. In conclusion, acute MPTP lesioning regimen in mice causes impairments in associative memory and conditioned fear, no mood changes, and depletion of dopamine and serotonin throughout the brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718537      PMCID: PMC3280725          DOI: 10.1016/j.nbd.2008.07.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  78 in total

1.  A functional role for dopamine transmission in the amygdala during conditioned fear.

Authors:  F A Guarraci; R J Frohardt; S L Young; B S Kapp
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

Review 2.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

3.  A selective role for corticosterone in contextual-fear conditioning.

Authors:  C R Pugh; D Tremblay; M Fleshner; J W Rudy
Journal:  Behav Neurosci       Date:  1997-06       Impact factor: 1.912

4.  The dopaminergic modulation of fear: quinpirole impairs the recall of emotional memories in rats.

Authors:  K Nader; J LeDoux
Journal:  Behav Neurosci       Date:  1999-02       Impact factor: 1.912

5.  Spaced training induces normal long-term memory in CREB mutant mice.

Authors:  J H Kogan; P W Frankland; J A Blendy; J Coblentz; Z Marowitz; G Schütz; A J Silva
Journal:  Curr Biol       Date:  1997-01-01       Impact factor: 10.834

Review 6.  Animal models of Parkinson's disease progression.

Authors:  Gloria E Meredith; Patricia K Sonsalla; Marie-Francoise Chesselet
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

7.  Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  V Jackson-Lewis; M Jakowec; R E Burke; S Przedborski
Journal:  Neurodegeneration       Date:  1995-09

Review 8.  Behavioral phenotyping strategies for mutant mice.

Authors:  Jacqueline N Crawley
Journal:  Neuron       Date:  2008-03-27       Impact factor: 17.173

9.  The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

Authors:  G Rozas; E López-Martín; M J Guerra; J L Labandeira-García
Journal:  J Neurosci Methods       Date:  1998-09-01       Impact factor: 2.390

10.  Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Authors:  Giselle M Petzinger; John P Walsh; Garnik Akopian; Elizabeth Hogg; Avery Abernathy; Pablo Arevalo; Patty Turnquist; Marta Vucković; Beth E Fisher; Daniel M Togasaki; Michael W Jakowec
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

View more
  34 in total

1.  Age- and duration-dependent effects of MPTP on cortical serotonin systems.

Authors:  Twum A Ansah; Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch
Journal:  Neurosci Lett       Date:  2011-09-21       Impact factor: 3.046

2.  Physical exercise attenuates MPTP-induced deficits in mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2010-03-19       Impact factor: 3.911

Review 3.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

4.  The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2013-07-27       Impact factor: 3.911

5.  Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.

Authors:  Lori M Gorton; Marta G Vuckovic; Nina Vertelkina; Giselle M Petzinger; Michael W Jakowec; Ruth I Wood
Journal:  Behav Brain Res       Date:  2010-05-21       Impact factor: 3.332

6.  5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

Authors:  Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch; Twum A Ansah
Journal:  Neuropharmacology       Date:  2010-03-31       Impact factor: 5.250

Review 7.  Behavioral phenotyping of mouse models of Parkinson's disease.

Authors:  Tonya N Taylor; James G Greene; Gary W Miller
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

8.  Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).

Authors:  Morgana Moretti; Vivian Binder Neis; Filipe Carvalho Matheus; Mauricio Peña Cunha; Priscila Batista Rosa; Camille Mertins Ribeiro; Ana Lúcia S Rodrigues; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2015-07-09       Impact factor: 3.911

9.  Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Lacey Pflibsen; Katherine A Stang; Michelle D Sconce; Vanessa B Wilson; Rebecca L Hood; Charles K Meshul; Suzanne H Mitchell
Journal:  J Neurosci Res       Date:  2015-08-31       Impact factor: 4.164

Review 10.  Beyond muscles: The untapped potential of creatine.

Authors:  Lisa A Riesberg; Stephanie A Weed; Thomas L McDonald; Joan M Eckerson; Kristen M Drescher
Journal:  Int Immunopharmacol       Date:  2016-01-08       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.